Skip to content
Govbase
Govbase
Congress·In Committee·S. 2426

Equitable Community Access to Pharmacist Services Act

Sen. Thune Leads Bipartisan Bill to Pay Pharmacists for Testing and Treating Flu, COVID-19, and Strep

This bill is currently in the early stages of the legislative process and is being reviewed by the Senate Committee on Finance. It is actively moving forward after being introduced in the Senate. There are no upcoming votes scheduled at this time.

Legislative Progress

Senate
House
President
Law
Could go either way

The bill has strong support from both parties and helps rural areas, but it still needs to pass through committees and both houses of Congress.

Key Points

Healthcare

Impact Analysis

Personal Impact

Life & Work

Independent pharmacy owners would gain a new revenue stream by being able to bill Medicare directly for testing and treating common respiratory illnesses and strep throat. This is particularly meaningful for small pharmacies in rural or underserved areas, where they may be the most accessible healthcare option for Medicare patients. The 85% of physician payment rate provides reasonable compensation for these services.

the amounts paid shall be equal to 80 percent of the lesser of (i) the actual charge for the services or (ii) 85 percent
3
3
2
5
+3
ImpactCertaintyScopeDurationSentiment

Programs

Disabilities

Milestones

2 milestones2 actions
Jul 24, 2025Senate

Read twice and referred to the Committee on Finance. (text: CR S4701)

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Jul 24, 2025

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Equitable Community Access to Pharmacist Services Act

Bill NumberS 2426
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance. (text: CR S4701)

Sponsor

Cosponsors

(29)
D: 15R: 14

Analysis generated by AI. Always verify with official sources.